Investigations into the CSF3R gene may help lead to better classification and precise treatment of AML.
Cancer patients with a documented history of depressive symptoms prior to hospital admission experience an extended hospital stay.
Baseline levels of lactate dehydrogenase are significantly associated with progression-free survival outcomes in patients with BRAF V600–mutated metastatic melanoma.
A study using multigene panel testing identified several pathogenic variants associated with an increased risk of triple-negative breast cancer.
A meta-analysis identified several factors that are correlated with locoregional recurrence in patients with nonmetastatic muscle-invasive bladder cancer.
Low-dose CT screening for lung cancer is recommended for certain individuals, but two new studies highlight some of the limitations and growing pains of a screening program.
The steep increase in thyroid cancer diagnosis has not been mirrored by increasing mortality rates and is likely due to widespread overdiagnosis of small neoplasms.
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis.
Patients treated with anti–PD-1 or anti–PD-L1 inhibitors in clinical trials were successfully retreated with the inhibitors after discontinuing the treatment.
A high level of resilience was associated with a better mental and physical health-related quality of life among patients with multiple myeloma.